Table 4 Comparative analysis of patients with and without DRPs
Total N = 269 | With DRPs N = 131 | Without DRPs N = 138 | P value | |
|---|---|---|---|---|
Total | 269 | 131 (48,7) | 138 (51,3) | |
Gender, n (%) | 0,034* | |||
Female | 130 (48,4) | 72 (55,0) | 58 (42,0) | |
Male | 139 (51,6) | 59 (45,0) | 80 (58,0) | |
Age (years) | 59,3 ± 15,6 | 60,6 ± 15,7 | 58,1 ± 15,4 | 0,184 |
BMI (kg/m2) | 26,9 ± 5,9 | 27,3 ± 6,2 | 26,6 ± 5,6 | 0,335 |
GFR (ml/min/1,73m2) | 38,6 ± 29,9 | 36,6 ± 28,2 | 40,5 ± 31,4 | 0,490 |
CKD grade, n (%) | 0,412 | |||
G 1–2 | 54 (20,1) | 21 (7,8) | 33 (12,3) | |
G 3a-3b | 77 (28,6) | 41 (15,2) | 36 (13,4) | |
G 4 | 85 (31,5) | 43 (15,9) | 42 (15,6) | |
G 5 | 52 (19,4) | 26 (9,7) | 26 (9,7) | |
Length of hospital stay, (days) | 10,3 ± 6,9 | 11,3 ± 7,7 | 9,3 ± 5,9 | 0,044** |
Number of comorbidities | 2,6 ± 1,5 | 2,7 ± 1,4 | 2,5 ± 1,6 | 0,460 |
Average number of medications used | 8,8 ± 3,6 | 9,6 ± 3,6 | 8,1 ± 3,5 | 0,002** |